ARS Pharmaceuticals Inc [SPRY] stock prices are up 3.24% to $10.51 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The SPRY shares have lost -0.47% over the last week, with a monthly amount drifted -19.28%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
ARS Pharmaceuticals Inc [NASDAQ: SPRY] stock has seen the most recent analyst activity on February 10, 2025, when Oppenheimer initiated its Outperform rating and assigned the stock a price target of $40. On August 13, 2024, upgrade upgraded it’s rating to Strong Buy and revised its price target to $22 on the stock. Leerink Partners reiterated its Outperform rating and increased its price target to $20 on August 12, 2024. Raymond James initiated its recommendation with a Outperform and recommended $18 as its price target on July 25, 2024. Leerink Partners upgraded its rating to Outperform for this stock on March 05, 2024, and upped its price target to $18. In a note dated February 20, 2024, William Blair upgraded an Outperform rating on this stock.
The stock price of ARS Pharmaceuticals Inc [SPRY] has been fluctuating between $7.55 and $18.51 over the past year. Currently, Wall Street analysts expect the stock to reach $23.33 within the next 12 months. ARS Pharmaceuticals Inc [NASDAQ: SPRY] shares were valued at $10.51 at the most recent close of the market. An investor can expect a potential return of 121.98% based on the average SPRY price forecast.
Analyzing the SPRY fundamentals
Gross Profit Margin for this corporation currently stands at 0.94% with Operating Profit Margin at -23.84%, Pretax Profit Margin comes in at -19.35%, and Net Profit Margin reading is -19.35%. To continue investigating profitability, this company’s Return on Assets is posted at -0.23, Equity is -0.23 and Total Capital is -0.3. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 10.10 points at the first support level, and at 9.69 for the second support level. However, for the 1st resistance point, the stock is sitting at 10.82, and for the 2nd resistance point, it is at 11.13.
Ratios To Look Out For
It’s worth pointing out that ARS Pharmaceuticals Inc [NASDAQ:SPRY]’s Current Ratio is 12.54. As well, the Quick Ratio is 12.50, while the Cash Ratio is 2.39. Considering the valuation of this stock, the price to sales ratio is 397.44, the price to book ratio is 5.08.
Transactions by insiders
Recent insider trading involved Shawver Laura, Director, that happened on Feb 03 ’25 when 50000.0 shares were sold. Director, Shawver Laura completed a deal on Feb 03 ’25 to buy 50000.0 shares. Meanwhile, Director Shawver Laura sold 50000.0 shares on Jan 06 ’25.
